Cyclerion Therapeutics, Inc.
CYCN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,232 | $7,571 | $13,382 | $53,961 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $556 | $0 | $96 | $100 |
| Inventory | $0 | $0 | $0 | $928 |
| Other Curr. Assets | $437 | $453 | $1,342 | $468 |
| Total Curr. Assets | $4,225 | $8,024 | $14,820 | $55,457 |
| Property Plant & Equip (Net) | $0 | $0 | $1,218 | $1,467 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $5,350 | $5,350 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $2,041 | $2,407 |
| Total NC Assets | $5,350 | $5,350 | $3,259 | $3,874 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $9,575 | $13,374 | $18,079 | $59,331 |
| Liabilities | – | – | – | – |
| Payables | $390 | $1,198 | $2,970 | $1,828 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $335 | $888 | $4,657 | $9,257 |
| Total Curr. Liab. | $725 | $2,086 | $7,627 | $11,085 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $725 | $2,086 | $7,627 | $11,085 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$267,492 | -$264,417 | -$259,154 | -$215,076 |
| AOCI | $0 | -$12 | -$20 | -$23 |
| Other Equity | $276,342 | $275,717 | $269,626 | $263,345 |
| Total Equity | $8,850 | $11,288 | $10,452 | $48,246 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $9,575 | $13,374 | $18,079 | $59,331 |
| Net Debt | -$3,232 | -$7,571 | -$13,382 | -$53,961 |